Comparable efficacy-safety and better renal function with everolimus and reduced-exposure tacrolimus versus standard-exposure tacrolimus in liver transplant recipients: H2304 and H2307 pooled analysis

被引：0

作者：

Levy, G. ^{[1
]}

Lee, S. G. ^{[2
]}

Jeng, L. -B ^{[3
]}

Soin, A. S. ^{[4
]}

Lee, W. -C ^{[5
]}

De Simone, P. ^{[6
]}

Nevens, F. ^{[7
]}

Suh, K. -S ^{[8
]}

Fischer, L. ^{[9
]}

Joo, D. J. ^{[10
]}

Fung, J. ^{[11
]}

Joh, J. -W ^{[12
]}

Kaido, T. ^{[13
]}

Grant, D. ^{[14
]}

Meier, M. ^{[15
]}

Sips, C. ^{[15
]}

Kaneko, S. ^{[16
]}

Saliba, F. ^{[17
]}

机构：

[1] Univ Toronto, Toronto, ON, Canada

[2] Asan Med Ctr, Seoul, South Korea

[3] China Med Univ Hosp, Taichung, Taiwan

[4] Medic Hosp, Medanta, Gurgaon, India

[5] Chang Gung Mem Hosp, Taoyuan, Taiwan

[6] Azienda Osped Univ Pisana, Pisa, Italy

[7] Univ Hosp Gasthuisberg, Leuven, Belgium

[8] Seoul Natl Univ, Coll Med, Seoul, South Korea

[9] Univ Med Ctr Eppendorf, Hamburg, Germany

[10] Yonsei Univ, Coll Med, Seoul, South Korea

[11] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA

[12] Samsung Med Ctr, Seoul, South Korea

[13] Kyoto Univ Hosp, Kyoto, Japan

[14] Toronto Gen Hosp, Toronto, ON, Canada

[15] Novartis Pharma AG, Basel, Switzerland

[16] Novartis Pharma KK, Tokyo, Japan

[17] Hop Paul Brousse, Villejuif, France

来源：

TRANSPLANTATION | 2019年 / 103卷 / 08期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

O-059

引用

页码：36 / 36

页数：1

共 47 条

[31] EVEROLIMUS WITH REDUCED TACROLIMUS DEMONSTRATES EFFICACY AND IMPROVED RENAL FUNCTION FOLLOWING LIVING-DONOR LIVER TRANSPLANTATION-12 MONTHS RESULTS FROM THE PIVOTAL H2307 STUDY
Lee, Sung-Gyu
Jeng, Long-Bin
Soin, Arvinder Singh
Lee, Wei-Chen
Uemoto, Shinji
El Meteini, Mahmoud
Lopez, Patricia
Kochuparampil, Jossy
Sips, Carole
Kaneko, Shuhei
Levy, Gary
TRANSPLANT INTERNATIONAL, 2017, 30 : 64 - 65
[32] Hephaistos Study Outcome on Renal Function after 12 Month Everolimus Plus Reduced Tacrolimus in De Novo Liver Transplant Recipients versus Standard Tacrolimus.
Braun, F.
Schemmer, P.
Schlitt, H.
Pascher, A.
Klein, C.
Neumann, U.
Kroeger, I.
Wimmer, P.
Nashan, B.
AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 556 - 556
[33] Everolimus-Facilitated Reduction Of Tacrolimus Provides Comparable Efficacy And Superior Renal Function Versus Standard Tacrolimus In De Novo Liver Transplant Recipients: 24-Month Results Of A Randomized Trial
Saliba, Faouzi
De Simone, Paolo
Nevens, Frederik
De Carlis, Luciano
Metselaar, Herold
Beckebaum, Susanne
Jonas, Sven
Sudan, Debra
Fischer, Lutz
Fung, John J.
Dong, Gaohong
Lopez, Patricia M.
Junge, Guido
HEPATOLOGY, 2012, 56 (06) : 1519 - 1519
[34] Efficacy and Safety of Everolimus With Reduced Tacrolimus in De Novo Liver Transplant Recipients: Long-Term Results From the H2304E1 Study.
Duvoux, C.
Saliba, F.
Kaiser, G.
De Carlis, L.
Metselaar, H.
De Simone, P.
Nevens, F.
Fischer, L.
Fung, J.
Dong, G.
Rauer, B.
Junge, G.
TRANSPLANTATION, 2014, 98 : 710 - 710
[35] Efficacy and Safety of Everolimus With Reduced Tacrolimus in De Novo Liver Transplant Recipients: Long-Term Results From the H2304E1 Study.
Duvoux, C.
Saliba, F.
Kaiser, G.
De Carlis, L.
Metselaar, H.
De Simone, P.
Nevens, F.
Fischer, L.
Fung, J.
Dong, G.
Rauer, B.
Junge, G.
AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 710 - 710
[36] EVEROLIMUS WITH REDUCED TACROLIMUS PRESERVES LONG-TERM RENAL FUNCTION IN LIVER TRANSPLANT RECIPIENTS: 36 AND 48 MONTHS RESULTS FROM THE H2304E1 STUDY
Saliba, F.
Durand, F.
Neau-Cransac, M.
Hardwigsen, J.
Pageaux, G.
Lopez, P.
Dong, G.
Di Giambattista, F.
Duvoux, C.
TRANSPLANT INTERNATIONAL, 2016, 29 : 7 - 7
[37] Everolimus With Reduced Tacrolimus Preserves Long-Term Renal Function in Liver Transplant Recipients: 36 and 48 Months Results From The H2304E1 Study
Fung, J.
Saliba, F.
Kaiser, G.
De Carlis, L.
Metselaar, H.
Nevens, F.
Duvoux, C.
De Simone, P.
Fischer, L.
Dong, G.
Rauer, B.
Junge, G.
TRANSPLANTATION, 2014, 98 : 180 - 180
[38] Everolimus With Reduced Tacrolimus Preserves Long-Term Renal Function in Liver Transplant Recipients: 36 and 48 Months Results From The H2304E1 Study
Fung, J.
Saliba, F.
Kaiser, G.
De Carlis, L.
Metselaar, H.
Nevens, F.
Duvoux, C.
De Simone, P.
Fischer, L.
Dong, G.
Rauer, B.
Junge, G.
AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 180 - 180
[39] Efficacy and Safety of Everolimus With Reduced Tacrolimus in Liver Transplant Recipients: 24-month Results From the Pooled Analysis of 2 Randomized Controlled Trials
Lee, Sung-Gyu
Jeng, Long-Bin
Saliba, Faouzi
Soin, Arvinder Singh
Lee, Wei-Chen
De Simone, Paolo
Nevens, Frederik
Suh, Kyung-Suk
Fischer, Lutz
Joo, Dong Jin
Fung, John
Joh, Jae-Won
Kaido, Toshimi
Grant, David
Meier, Matthias
Rauer, Barbara
Sips, Carole
Kaneko, Shuhei
Levy, Gary
TRANSPLANTATION, 2021, 105 (07) : 1564 - 1575
[40] EARLY EVEROLIMUS PLUS REDUCED TACROLIMUS VERSUS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS RESULTS IN SUPERIOR RENAL FUNCTION AND SUSTAINS OVER 24 MONTHS: RESULTS OF A RANDOMIZED TRIAL
De Simone, P.
Fischer, L.
Kaiser, G.
Jonas, S.
Heise, M.
Schemmer, P.
Pascher, A.
Schlitt, H.
Paulus, E.
Mertens, M.
Duvoux, C.
TRANSPLANT INTERNATIONAL, 2013, 26 : 3 - 3

← 1 2 3 4 5 →